Skip to main content
. Author manuscript; available in PMC: 2018 Mar 5.
Published in final edited form as: Br J Haematol. 2016 Dec 16;176(5):750–758. doi: 10.1111/bjh.14477

Figure 2. A, Failure-free survival after first, second and third progression/relapse for PTCL-NOS; B, Overall survival after first, second and third progression/relapse for PTCL-NOS; C, Failure-free survival after first, second and third progression/relapse for AITL; D, Overall survival after first, second and third progression/relapse for AITL.

Figure 2

AITL, angioimmunoblastic T-cell lymphoma; FFS, failure-free survival; OS, overall survival; PTCL-NOS, peripheral T-cell lymphoma-not otherwise specified.